Concentric by Ginkgo

What Concentric by Ginkgo does

Concentric by Ginkgo operates a biosecurity infrastructure platform branded as the Biothreat Radar, structured around four integrated modules: Detect (layered collection modalities deployed across airports, hospitals, wastewater systems, and critical infrastructure), Characterize (computational biology paired with frontier AI to identify and risk-grade circulating threats), Respond (synthesized intelligence delivered for operational decision-making), and Forecast (custom and off-the-shelf biological risk models across time and geography). Underpinning the platform is the ENDAR (Engineered Nucleotide Detection and Ranking) toolkit — a first-of-its-kind capability developed under the IARPA FELIX program and validated across four T&E exercises with US National Labs — which detects genetic engineering signatures as small as 50 base pairs at up to 10x back-dilution. The company is best known for operating the only traveler-based pathogen genomic surveillance network in the US, deployed across 8 international airports since 2021 and capturing biological intelligence from 135+ countries of origin via 1M+ volunteer travelers and 2,600+ wastewater samples. International biosurveillance nodes extend operations to Africa, the Middle East, Ukraine, and Georgia.

The business sells subscription-based biosecurity infrastructure through a consultative enterprise sales process — 'Request Briefing' rather than self-serve — to four named customer segments: government agencies and public health authorities (primary), military and defense, healthcare systems and hospitals, and critical infrastructure operators. Named deployments include California Department of Public Health (triggered by early detection of H3N2 subclade K, 'super flu') and a US Military Treatment Facility (vancomycin-resistant Enterococci detection one week ahead of clinical identification). A pan-clade Mpox Clade Ib wastewater PCR assay developed within ~3 weeks in 2024 is distributed as an off-the-shelf kit through the Association of Public Health Laboratories. Pricing is quote-based and not publicly disclosed.

The business model is anchored on recurring subscription revenue from mission-critical biosurveillance contracts with government, defense, and large-enterprise customers, supplemented by diagnostic kit distribution through public health channels. Note: firmographics in the source data list 5 employees at a Boston, Massachusetts headquarters, while operational descriptions, international footprint, and program scale are inconsistent with a team of that size — this represents a material data integrity gap between scraped firmographic fields and the operational narrative that should be reconciled before diligence.

Name

Concentric by Ginkgo

Legal name

Perimeter

Website

https://concentricbyginkgo.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Concentric by Ginkgo operates a biosecurity infrastructure platform (Biothreat Radar) that forecasts, detects, and characterizes biological threats using metagenomic sequencing and frontier AI. It serves government agencies, military and defense, healthcare systems, and critical infrastructure operators worldwide through subscription-based enterprise contracts.

Ownership category

akta.pro rank

Product category

Biosecurity & Biological Threat Intelligence

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215), Computer Systems Design and Related Services (54151)

SIC

Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Public Health Genomics & Sequencing (WGS/Metagenomics) Networks (HLAJAIAK)

akta.pro secondary industries

Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS) (HLAJABAC), Emerging Pathogen & Outbreak Response Testing Networks (HLAJAIAE), Modeling, Forecasting & Risk Assessment for Outbreaks (HLAJABAM), Zoonotic & One Health Surveillance (HLAJABAF), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

• Biosecurity infrastructure
• Biological threat detection
• Genomic surveillance services
• Pathogen monitoring platform
• Metagenomic sequencing analytics

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Biosecurity Infrastructure Services: Subscription-based biosecurity infrastructure providing continuous threat monitoring, detection, characterization, and response capabilities. Services are customized to organizational mission needs including planning for personnel surge, continuity of operations, force projection, public health guidance, economics and resource planning, and countermeasure development.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Concentric by Ginkgo (operating publicly as Perimeter) builds and operates an always-on biosecurity infrastructure platform called Biothreat Radar. The platform combines distributed sampling networks, metagenomic sequencing, computational biology, and AI to forecast, detect, characterize, and respond to biological threats across airports, hospitals, wastewater systems, and conflict zones. It also develops specialized capabilities such as the ENDAR genetic engineering detection toolkit and the Traveler-Based Genomic Surveillance (TGS) program.

Product overview

Perimeter offers a unified biosecurity platform called Biothreat Radar with four integrated modules: Detect (layered collection modalities including wastewater and sampling), Characterize (computational biology with frontier AI), Respond (synthesized intelligence for decisive action), and Forecast (custom risk models across time and geography). Supporting capabilities include ENDAR for engineered nucleotide detection and the TGS traveler-based genomic surveillance program. The platform is deployed at airports, hospitals, military facilities, and conflict zones worldwide, providing continuous biological threat monitoring and early warning.

Differentiator

Problem solved

Functional benefit

Brands

• ENDAR: Engineered Nucleotide Detection and Ranking system - first-of-its-kind analysis toolkit that distinguishes genetic engineering from natural evolution or sequencing noise. Developed in collaboration with IARPA under the FELIX program, detecting genetic manipulations as small as 50 base pairs in viruses, bacteria, fungi, and plants.
• Biothreat Radar
• Biothreat Digest

Products and services

• Biothreat Radar Platform An always-on biosecurity infrastructure platform that forecasts and detects biological threats as they emerge, characterizes risk for specific operational contexts, and guides intelligent response for government, defense, healthcare, and critical infrastructure organizations.
• ENDAR (Engineered Nucleotide Detection and Ranking) First-of-its-kind analysis toolkit that distinguishes genetic engineering from natural evolution or sequencing noise in viruses, bacteria, fungi, and plants, detecting manipulations as small as 50 base pairs at up to 10x back-dilution into non-engineered parental strains.
• Traveler-Based Genomic Surveillance (TGS) A deployed airport-based pathogen genomic surveillance network operating across 8 international airports, capturing biological samples from over one million international traveler volunteers and 2,600+ wastewater samples since 2021.
• Pan-Clade Mpox Wastewater PCR Assay A wastewater PCR assay that detects across multiple mpox clades, including Mpox Clade Ib, designed for public health laboratories and deployed in biosurveillance programs in Africa and the Middle East.

Quantifiable outcome

• Identified novel H3N2 subclade K ('super flu') 7 days before it appeared in any public repository, enabling proactive public health planning
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core and major.

• Association of Public Health Laboratories (APHL)coreChannel Partner/ Reseller/ Distributor · 1 January 2024Perimeter's pan-clade wastewater PCR assay for Mpox Clade Ib is available as an off-the-shelf kit through APHL, enabling broad distribution to public health laboratories across the United States. This partnership extends the reach of Perimeter's rapidly developed detection capability to the wider public health infrastructure.
• Defense Centers for Public Health-AberdeencoreStrategic or Co-development PartnerThe Defense Centers for Public Health-Aberdeen validated Perimeter's pan-clade wastewater PCR assay for Mpox detection. This military public health validation supports the assay's deployment across Perimeter's operational biosurveillance programs in Africa and the Middle East.
• IARPA (Intelligence Advanced Research Projects Activity)coreStrategic or Co-development PartnerPerimeter developed its ENDAR (Engineered Nucleotide Detection and Ranking) system in collaboration with IARPA under the FELIX program (Finding Engineering-Linked Indicators). The system was validated through 4 T&E exercises with US National Labs, ranking first among dry lab performers and delivering a novel genetic engineering detection capability.
• US National LaboratoriesmajorStrategic or Co-development PartnerPerimeter's ENDAR genetic engineering detection system was validated through 4 Technology & Engineering (T&E) exercises with US National Laboratories, establishing credibility and technical validation for its novel biosecurity detection capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Battelle: Nonprofit applied science organization operating major U.S. biodefense labs (e.g., NBL) and biosurveillance programs for DHS, DoD, and HHS. Comparable as an established, federally validated biodefense infrastructure provider that Perimeter competes against for defense and homeland security contracts.
• Leidos: Large defense and health IT prime contractor running biodefense and public health surveillance programs for CDC, BARDA, and DoD. Comparable as a scaled government services incumbent that Perimeter competes with on integrated biosurveillance and forecasting procurements.
• Ginkgo Bioworks: The publicly traded synthetic biology platform that incubated Concentric / Perimeter as its biosecurity subsidiary ('Concentric by Ginkgo'). Closely related through origin, customer overlap, and synthetic biology IP, though Ginkgo's core business is organism engineering rather than biosurveillance.
• Emergent BioSolutions: Biodefense-focused specialty biopharmaceutical company supplying anthrax, smallpox, and other medical countermeasures to U.S. government. Adjacent to Perimeter as a biodefense countermeasure partner/customer, though it sits downstream in the response chain rather than upstream in detection.
• BioFire Diagnostics (bioMérieux): Subsidiary of bioMérieux that manufactures syndromic PCR panels widely deployed in clinical and public health labs. Comparable as a public-health infectious disease diagnostics platform, though BioFire's focus is on clinical sample panels rather than wastewater/airport surveillance.
• Booz Allen Hamilton: Management and technology consulting firm with deep biodefense and public health analytics practices serving federal agencies. Comparable as an incumbent integrator competing for the same government biosecurity and threat-intelligence program dollars.
• B.Next (Bruker): Bruker's biodefense and biosurveillance subsidiary, offering MALDI Biotyper-based detection and metagenomic workflows for government and clinical customers. Comparable as a molecular detection competitor serving similar federal biodefense buyers.

Emerging players

• PandemicTech: Venture-backed global health security company investing in and deploying outbreak detection and response technologies in low-resource settings. Comparable as a smaller, emerging player working on the international biosurveillance footprint that Perimeter is also building.
• HealthMap (Boston Children's Hospital): Academic, open-source disease outbreak monitoring platform aggregating global surveillance signals. Comparable as an emerging player offering automated infectious disease surveillance and forecasting, though without Perimeter's proprietary wet-lab network.

Direct peers

• BlueDot: Toronto-based infectious disease intelligence platform using AI and global data sources to forecast outbreaks. Most direct comparable to Perimeter's forecasting and threat-characterization offering, serving public health agencies and governments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/concentric-by-ginkgo

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Concentric by Ginkgo